# A Safety, Tolerability, Pharmacokinetic and Efficacy Study of Azithromycin Plus Piperaquine as Presumptive Treatment in Pregnant PNG Women

> **NCT02575755** · PHASE4 · UNKNOWN · sponsor: **Papua New Guinea Institute of Medical Research** · enrollment: 150 (estimated)

## Conditions studied

- Pregnancy
- Infections, Plasmodia
- Drug Kinetics
- Clinical Efficacy

## Interventions

- **DRUG:** Azithromycin plus piperaquine phosphate
- **DRUG:** Sulfadoxine-pyrimethamine

## Key facts

- **NCT ID:** NCT02575755
- **Lead sponsor:** Papua New Guinea Institute of Medical Research
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-10
- **Primary completion:** 2016-07
- **Final completion:** 2016-10
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2015-10-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02575755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02575755, "A Safety, Tolerability, Pharmacokinetic and Efficacy Study of Azithromycin Plus Piperaquine as Presumptive Treatment in Pregnant PNG Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02575755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*